Sequence
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4590 Lockhill Selma Rd, San Antonio, Tex...Phone Number
(210) 545-3713Website
www.sequencelifesci.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sequence
Sequence LifeScience, Inc. is a premier human tissue allograft processing facility established in 2021, dedicated to ethically advancing human healing through high-quality human cell and tissue products. The company focuses on providing placental-derived allograft products that serve as biologic barriers for acute and chronic wound applications, ensuring safety and efficacy through rigorous quality management. Their services include contract manufacturing and private label opportunities for OEMs, emphasizing customer satisfaction and compliance with regulatory standards. Sequence LifeScience partners with recovery organizations to maximize the gift of tissue donation while maintaining the highest safety protocols.Explore more
Sequence Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sequence your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sequence has new funding data
Click to see if Sequence had a recent Job posting/layoffs
Sequence, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sequence recently announced quarterly report
Check if Sequence has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sequence launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sequence
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sequence is spiking on competitors!
Recommended Actions
Find VP level buyers at Sequence
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sequence is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sequence is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sequence.
Sequence Tech Stack
A closer look at the technologies used by Sequence
See more technologies
Sequence News & Media
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
Transaction expected to approximately triple NEXGEL’s annual revenue to approximately $35 million and is expected to be immediately accretive to profitabilitySequence LifeScience, Inc. Announces First Patient Enrolled in Groundbreaking Clinical Trial for Diabetic Foot Ulcers
SAN ANTONIO, Oct. 8, 2025 /PRNewswire/ -- Sequence LifeScience Inc., a leader in allograft tissue processing, today announced a major milestone in its clinical development program: the first patient has been enrolled and treatment initiated in the company's innovative multicenter,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sequence
Sign Up For FreeTo access detailed company insights
Sequence LifeScience, Inc. is a premier human tissue allograft processing facility established in 2021, dedicated to ethically advancing human healing through high-quality human cell and tissue products. The company focuses on providing placental-derived allograft products that serve as biologic barriers for acute and chronic wound applications, en... Read More
